Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death

T.E. Verstraelen*, M. van Barreveld*, P.H.F.M. van Dessel, L.V.A. Boersma, P.P.P.H.M. Delnoy, A.E. Tuinenburg, D.A.M.J. Theuns, P.H. van der Voort, G.P. Kimman, E. Buskens, M. Hulleman, C.P. Allaart, S. Strikwerda, M.F. Scholten, M. Meine, R. Abels, A.H. Maass, M. Firouzi, J.W.M.G. Widdershoven, J. EldersM.W.F. van Gent, M. Khan, K. Vernooy, R.W. Grauss, R. Tukkie, L. van Erven, H.A.M. Spierenburg, M.A. Brouwer, G.L. Bartels, N.R. Bijsterveld, A.E.B. van der Burg, M.W. Vet, R. Derksen, R.E. Knops, F.A.L.E. Bracke, M. Harden, C. Sticherling, R. Willems, T. Friede, M. Zabel, M.G.W. Dijkgraaf, A.H. Zwinderman, A.A.M. Wilde

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)887-897
Number of pages11
JournalEP Europace
Volume23
Issue number6
DOIs
Publication statusPublished - 1 Jun 2021

Keywords

  • Implantable cardioverter-defibrillator
  • Primary prevention
  • Risk factors
  • Mortality
  • Sudden cardiac death
  • Prediction models
  • RISK STRATIFICATION
  • GUIDELINES
  • MANAGEMENT
  • DIAGNOSIS
  • BENEFITS
  • THERAPY
  • ESC

Cite this